Pros and cons of TIPS for refractory ascites

Journal of Hepatology

Volumn 43, Issue 6, 2005, Pages 924-925

  Sanyal, A J ^a  

^a Division of Gastroenterology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; NEOMYCIN; RIFAXIMIN;

ASCITES; BRAIN DISEASE; CLINICAL TRIAL; DECOMPRESSION SURGERY; EDITORIAL; HEMODYNAMICS; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; META ANALYSIS; MORTALITY; NEUROLOGICAL COMPLICATION; NUTRITION; PARACENTESIS; PATIENT SELECTION; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT INDICATION;

ASCITES; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERTENSION, PORTAL; KIDNEY DISEASES; LIVER CIRRHOSIS; LIVER FAILURE; MALNUTRITION; NUTRITIONAL STATUS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 27744539433     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.09.006     Document Type: Editorial

References (12)

1. P. Gines, V. Arroyo, V. Vargas, R. Planas, F. Casafont, and J. Panes Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites N Engl J Med 325 1991 829 835
2. P. Gines, L. Tito, V. Arroyo, R. Planas, J. Panes, and J. Viver Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis Gastroenterology 94 1988 1493 1502
3. A. Albillos, R. Bañares, M. González, M.-V. Catalina, and L.-M. Molinero A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites J Hepatol 43 2005 990 996
4. E. Lotterer, A. Wengert, and W.E. Fleig Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis Hepatology 29 1999 632 639
5. F. Wong, K. Sniderman, P. Liu, Y. Allidina, M. Sherman, and L. Blendis Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites Ann Intern Med 122 1995 816 822
6. A. Montgomery, H. Ferral, R. Vasan, and D.W. Postoak MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures Cardiovasc Intervent Radiol 28 2005 307 312
7. A.J. Sanyal, A.M. Freedman, M.L. Shiffman, P.P. Purdum III, V.A. Luketic, and A.K. Cheatham Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study Hepatology 20 1994 46 55
8. L. Spahr, D. Fenyves, V.V. N'Guyen, L. Roy, L. Legault, and M.P. Dufresne Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt Am J Gastroenterol 90 1995 1169 1171
9. M. Schepke, F. Roth, L. Koch, J. Heller, C. Rabe, and K.A. Brensing Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleeding Digestion 67 2003 146 153
10. A. Ochs, M. Rossle, K. Haag, K.H. Hauenstein, P. Deibert, and V. Siegerstetter The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites N Engl J Med 332 1995 1192 1197
11. K.A. Brensing, J. Textor, J. Perz, P. Schiedermaier, P. Raab, and H. Strunk Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study Gut 47 2000 288 295
12. J.M. Schwartz, C. Beymer, S.J. Althaus, A.M. Larson, A. Zaman, and D.J. Glickerman Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts: role of increased pulmonary artery pressure J Clin Gastroenterol 38 2004 590 594